New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaksBOSTON, ...
5h
News Medical on MSNIgE antibodies show promise in targeting HER2 cancers resistant to other therapiesAntibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results